Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: This still eats at me: ...Markman, ITC, So What...?

I posed this question in a different form a few years ago, and some here got pretty mad about the implied threat to all our hopes:

An entity with a pile of cash is not a business with a product or service, so why would having a pile of cash in the form of license fees make PTSC shares rise significantly?

How do a final, positive and publicized Markman ruling and a favorable ITC ruling transform PTSC into a normal company with not only a pile of cash but a future worthy of selling shares in?

What will PTSC produce, PDS? Come on... Merely dividends? Is that enough for a siginificant SP rise?

What would make it more than a plaything for the BOD and market makers; what the h--- is this thing anymore?

By the way, I've been in it since 1999, attracted by an actual, physical product they once made...

Share
New Message
Please login to post a reply